{
  "id": 9776321,
  "title": "Legend's five-year data suggests Carvykti could be a cure; Addex, Indivior split",
  "url": "https://urgent.news/2026/09/25/legends-five-year-data-suggests-carvykti-could-be-a-cure-addex",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-25T14:34:34.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/legends-five-year-data-suggests-carvykti-could-be-a-cure-addex-indivior-split/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Amberstone, Henlius and Boehringer Ingelheim. Legend adds to argument for Carvykti as a cure: Legend Biotech said Friday that 10 of 20 relapsed/refractory multiple myeloma patients who received ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}